Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Hiroshi Kazama"'
Publikováno v:
Journal of Immunology Research, Vol 2024 (2024)
Multiple myeloma (MM) is an intractable hematological malignancy caused by abnormalities in plasma cells. Combination therapy using antibodies and natural killer (NK) effectors, which are innate immune cells with safe and potent antitumor activity, i
Externí odkaz:
https://doaj.org/article/27e2c552273445f5b7a6b045d6e6e965
Autor:
Junji Tanaka, Norina Tanaka, Yan-Hua Wang, Kenjiro Mitsuhashi, Michiko Ryuzaki, Yuki Iizuka, Aya Watanabe, Midori Ishiyama, Akihito Shinohara, Hiroshi Kazama, Shotaro Hagiwara, Kentaro Yoshinaga, Yumi Kougen, Hirohito Kobayashi, Hitoshi Kanno, Masayuki Shiseki
Publikováno v:
Haematologica, Vol 105, Iss 4 (2020)
Externí odkaz:
https://doaj.org/article/217b9b5923bc4608a54b1490e400b057
Publikováno v:
Case Reports in Medicine, Vol 2012 (2012)
Primary bone marrow diffuse large B-cell lymphoma (DLBCL) is a rare type of extranodal lymphoma with poor prognosis. Here, we report a case of primary bone marrow DLBCL successfully treated with high-dose chemotherapy and rescued by in vivo rituximab
Externí odkaz:
https://doaj.org/article/ce73eaa5c5e24b59990014b20ab6da2e
Autor:
Satoko Osanai, Akihito Shinohara, Maya Kobayashi, Michiko Ryuzaki, Midori Ishiyama, Junji Tanaka, Norina Tanaka, Shoko Oshima, Kentaro Yoshinaga, Yuki Izuka, Masayuki Shiseki, Megumi Oishi, Hiroshi Kazama, Shotaro Hagiwara, Aya Watanabe
Publikováno v:
Internal Medicine
We herein report two cases of thrombotic thrombocytopenic purpura (TTP) complicated by other autoimmune disorders, autoimmune hepatitis and immune thrombocytopenia, respectively. In both cases, corticosteroids were continuously administered for the t
Autor:
Yumi Kougen, Junji Tanaka, Akihito Shinohara, Hirohito Kobayashi, Michiko Ryuzaki, Yuki Iizuka, Hitoshi Kanno, Norina Tanaka, Kenjiro Mitsuhashi, Shotaro Hagiwara, Masayuki Shiseki, Hiroshi Kazama, Kentaro Yoshinaga, Aya Watanabe, Yan-Hua Wang, Midori Ishiyama
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::383c119716b570c9fde30daa42653b56
https://europepmc.org/articles/PMC7109741/
https://europepmc.org/articles/PMC7109741/
Autor:
Yuki Izuka, Akihito Shinohara, Junji Tanaka, Aya Watanabe, Satoko Osanai, Kentaro Yoshinaga, Hiroshi Kazama, Shotaro Hagiwara, Michiko Ryuzaki, Masayuki Shiseki, Norina Tanaka, Midori Ishiyama
Publikováno v:
British Journal of Haematology. 186
Autor:
Aya Watanabe, Masayuki Shiseki, Megumi Oishi, Maya Kobayashi, Shoko Oshima, Satoko Osanai, Michiko Ryuzaki, Yuki Izuka, Norina Tanaka, Midori Ishiyama, Akihito Shinohara, Hiroshi Kazama, Shotaro Hagiwara, Kentaro Yoshinaga, Junji Tanaka
Publikováno v:
Internal Medicine; 2021, Vol. 60 Issue 17, p2859-2862, 4p
Autor:
Kenjiro Mitsuhashi, Keiichi Moriya, Yoichi Imai, Michihiko Masuda, Toshiko Motoji, Aya Watanabe, Noriko Isono, Hiroshi Kazama, Hideto Tamura, Hiroki Sugimori, Chihiro Asano, Junji Tanaka, Hanae Shimura, Koiti Inokuchi
Publikováno v:
Leukemia & Lymphoma. 57:2204-2207
Bendamustine is a novel alkylator containing a benzimidazole ring, which adds purine analogue-like properties in addition to the alkylating properties.[1] Several clinical studies have showed that ...
Publikováno v:
2017 International Conference on Intelligent Informatics and Biomedical Sciences (ICIIBMS).
For pedestrian traffic, pushbutton traffic signals are used. However, pushbutton signal machines are often installed in inconvenient locations. Therefore, a new method is required to allow pedestrians to switch the traffic signals using a crossing re
Autor:
Norina Tanaka, Kentaro Yoshinaga, Aya Watanabe, Yutaka Kato, Yuki Iizuka, Hiroshi Kazama, Masayuki Shiseki, Yan-Hua Wang, Hitoshi Kanno, Midori Ishiyama, Akihito Shinohara, Junji Tanaka, Hirohito Kobayashi, Shotaro Hagiwara
Publikováno v:
Blood. 134:3133-3133
Recent advances of monoclonal antibodies provide a potent anti-myeloma effect based on antibody-dependent cytotoxicity (ADCC). Elotuzumab is a monoclonal antibody which binds SLAMF7 on the surface of myeloma cells and induces ADCC by NK cells (Cancer